Related Experiment Video

Updated: Mar 21, 2026

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

22.7K

Serotypage Des Pneumocoques (Hemocultures Et Ponctions Tracheales), Sensibilite Aux Antibiotiques Et Considerations

F Crokaert1, M Blogie1, T Prigoginc1

  • 1a Hopital Universitaire Brugmann , departcment de Biologic Clinique , avenue J .J. CrocqI, 1020 Bruxelles.

Acta Clinica Belgica
|May 19, 2016
PubMed

Insights

A 14-valent vaccine could cover 67% of predominant serotypes 3 and 4 from blood cultures and transtracheal aspirations, potentially protecting 53% of patients. Further clinical trials are recommended due to 80% vaccine efficacy evaluation.

Area of Science:

  • Medical Microbiology
  • Immunology
  • Vaccinology

Background:

  • Prevalence of specific serotypes in bloodstream infections and respiratory tract infections is crucial for vaccine development.
  • Understanding antimicrobial resistance patterns is essential for effective treatment strategies.

Purpose of the Study:

  • To serotype 114 bacterial strains isolated from blood cultures and transtracheal aspirations.
  • To evaluate the potential coverage of a 14-valent vaccine against these predominant serotypes.
  • To assess the need for a controlled clinical trial for vaccine efficacy.

Main Methods:

  • Bacterial strains were isolated using blood cultures and transtracheal aspirations.
  • Serotyping was performed to identify the predominant strains.
  • Vaccine coverage and potential patient protection were calculated based on serotype prevalence and vaccine efficacy.

Main Results:

  • Serotypes 3 and 4 were the most predominant among the 114 analyzed strains.
  • A 14-valent vaccine (serotypes 1, 2, 3, 4, 6, 8, 9, 12, 14, 19, 23, 25, 51, 56) could cover 67% of the isolated strains.
  • The vaccine might protect 53% of patients, considering an 80% efficacy rate.

Conclusions:

  • The 14-valent vaccine shows significant potential for covering predominant serotypes found in blood cultures and transtracheal aspirations.
  • A controlled clinical trial is warranted to confirm the vaccine's efficacy and protective capacity in patients.
  • While no penicillin resistance was observed, 14% of strains exhibited tetracycline resistance, highlighting the importance of monitoring antimicrobial susceptibility.

More Related Videos

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction04:25

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Published on: February 24, 2014

46.8K
Experimental Human Pneumococcal Carriage07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

16.4K

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
9
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
1.7K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.2K